SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT-ov78).

Authors: Benoit You, Nozomu Yanaihara, Gabriella Parma, Sylvie Chabaud, Laura Del Carpio, Andrew R. Clamp, Gwenael Ferron, Judith R. Kroep, Alexandra Leary, David Cibula, Frédéric Fiteni, Ilan Bruchim, Hassan Serrier, Susannah Catherine Carroll, Anne-Sophie Belmont, Julien Peron, Claire Chator

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5626

Source: Full article

---

Abstract

TPS5626